HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of lipanthyl on mRNA expression of endothelin-1 and nitric-oxide synthase in atherosclerotic vessel wall in rabbits.

AbstractAIM:
To study the mechanism of regression of atherosclerosis (AS) by lipanthyl.
METHODS:
Experimental atherosclerotic rabbits created by damaging the abdominal aortic endothelium and feeding with high fat diet for 8 wk were then treated with lipanthyl 15 mg.kg-1.d-1 for 16 wk. Expression of endothelin (ET)-1 mRNA and nitric oxide synthase (NOS) mRNA in atherosclerotic vessel wall was measured by in situ hybridization and reverse transcription polymerase chain reaction (RT-PCR), respectively.
RESULTS:
After lipanthyl administration for 16 wk, ET-1 mRNA expression was reduced, and integral optical density (IOD) and area of hybridization granule were observed to be (49,113 +/- 16,868) and (2448 +/- 621) micron 2 in lipanthyl group and (65,188 +/- 10,113) and (3028 +/- 352) micron 2 in atherosclerotic group, respectively. Regarding inducible NOS mRNA expression, IOD and area were decreased by 25.5% and 53.3%, respectively, whereas endothelial NOS mRNA expression was increased.
CONCLUSION:
Restoration of the disturbed ET-1 mRNA/NOS mRNA balance by lipanthyl might be one of its mechanisms leading to regression of atherosclerosis.
AuthorsM L Xie, Z L Gu, K J Chen, W X Zhou, C Y Guo
JournalActa pharmacologica Sinica (Acta Pharmacol Sin) Vol. 21 Issue 5 Pg. 473-6 (May 2000) ISSN: 1671-4083 [Print] United States
PMID11324450 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Endothelin-1
  • Hypolipidemic Agents
  • RNA, Messenger
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Fenofibrate
Topics
  • Animals
  • Aorta, Abdominal (metabolism)
  • Arteriosclerosis (metabolism)
  • Endothelin-1 (biosynthesis, genetics)
  • Fenofibrate (pharmacology)
  • Hypolipidemic Agents (pharmacology)
  • Male
  • Nitric Oxide Synthase (biosynthesis, genetics)
  • Nitric Oxide Synthase Type II
  • RNA, Messenger (biosynthesis, genetics)
  • Rabbits
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: